Abstract
Acute kidney injury (AKI) impairs short- and long-term prognosis of affected patients even in case of apparantly mild course and 'full' recovery as measured by follow-up serum creatinine concentrations. Late or none intervention worsens prognosis. However, there are modifiable factors potentially contributing to preserved long-term renal function. Effective treatment is multifactorial and includes identification and reversal of AKI etiology and generation of a (micro)environment for optimal renal recovery. Available treatment options for AKI in perioperative and critically ill patients will be discussed in the setting of novel kidney biomarkers.
© Georg Thieme Verlag Stuttgart · New York.
MeSH terms
-
Acute Kidney Injury / blood*
-
Acute Kidney Injury / diagnosis
-
Biomarkers / blood
-
Creatinine / blood*
-
Critical Illness
-
Cystatin C / blood*
-
Evidence-Based Medicine
-
Humans
-
Insulin-Like Growth Factor Binding Proteins / blood
-
Intraoperative Complications / blood*
-
Intraoperative Complications / diagnosis
-
Lipocalin-2 / blood*
-
Monitoring, Intraoperative / methods
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Tissue Inhibitor of Metalloproteinase-2 / blood*
Substances
-
Biomarkers
-
Cystatin C
-
Insulin-Like Growth Factor Binding Proteins
-
LCN2 protein, human
-
Lipocalin-2
-
insulin-like growth factor binding protein-related protein 1
-
Tissue Inhibitor of Metalloproteinase-2
-
Creatinine